Dept. of Defense - CDMRP Multiple Sclerosis Research Program. LOI due 8/2/22. $20M Available.
Multiple Sclerosis Research Program (MSRP)
Applications to the Fiscal Year 2022 (FY22) Multiple Sclerosis Research Program (MSRP) are being solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using delegated authority provided by United States Code, Title 10, Section 4001 (10 USC 4001). The execution management agent for this program announcement is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC). The MSRP was initiated in 2009 to provide support for pioneering concepts and high-impact research that are relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis (MS) to ultimately lessen its personal and societal impact. Appropriations for the MSRP from FY09 through FY21 totaled $93.1 million (M). The FY22 appropriation is $20.0M. The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public.
Organization: All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply.
Government Agencies Within the United States: Local, state, and federal government agencies are eligible to the extent that applications do not overlap with their fully funded internal programs. Such agencies are required to explain how their applications do not overlap with their internal programs. As applications for this program announcement may be submitted by extramural and intramural organizations, these terms are defined below.
Extramural Organization: An eligible non-DOD organization. Examples of extramural organizations include academic institutions, biotechnology companies, foundations, federal government organizations other than the DOD, and research institutes.
Intramural DOD Organization: A DOD laboratory, DOD military treatment facility, and/or DOD activity embedded within a civilian medical center.
Intramural Submission: An application submitted by a DOD organization for an intramural investigator working within a DOD laboratory or military treatment facility or in a DOD activity embedded within a civilian medical center.
The USAMRAA makes awards to eligible organizations, not to individuals.
Total Amount Available:
Letter of Intent due August 2, 2022
Confidential Letters of Recommendation due October 6, 2022
Full Applications due October 3, 2022
Grant Management Associates has years of experience with opportunities like this one. Contact us today for a consultation.